SEARCH

SEARCH BY CITATION

References

  • 1
    Adams, J.M., Harris, A.W., Pinkert, C.A., Corcoran, L.M., Alexander, W.S., Cory, S., Palmiter, R.D., Brinster, R.L. (1985) The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature, 318, 533 538.
  • 2
    Aisenberg, A.C. (1999a) Primary large cell lymphoma of the mediastinum. Seminars in Oncology, 26, 251 258.
  • 3
    Aisenberg, A.C. (1999b) Problems in Hodgkin's disease management. Blood, 93, 761 779.
  • 4
    Aisenberg, A.C. & Bloch, K.J. (1972) Immunoglobulins on the surface of neoplastic lymphocytes. New England Journal of Medicine, 287, 272 276.
  • 5
    Aisenberg, A.C., Krontiris, T.G., Mak, T.W., Wilkes, B.M. (1985) Rearrangement of the gene for the beta chain of the T-cell receptor in T-cell chronic lymphocytic leukemia and allied disorders. New England Journal of Medicine, 313, 529 533.
  • 6
    Aur, R.J.A., Hustu, H.O., Simone, J.V., Pinkel, D. (1970) Therapy of localized and regional lymphosarcoma of childhood. Cancer, 27, 1328 1331.
  • 7
    Banks, P., Chan, J., Cleary, M., Delson, G., De Wolf-Peeter, C., Gatter, K., Grogan, T., Harris, N., Isaacson, P., Jaffer, E., Mason, D., Pileri, S., Ralfkiaer, E., Stein, H., Warnke, R. (1992) Mantle cell lymphoma: a proposal for unification of morphologic, immunologic, and molecular data. American Journal of Surgical Pathology, 16, 637 640.
  • 8
    Barcos, M.P. & Lukes, R.J. (1975) Malignant lymphomas of convoluted lymphocytes. A new entity of possible T-cell type. In: Conflicts in Childhood Cancer. An Evaluation of Current Management (ed. by L.F. & J.O.Godden), Vol. 4, p. 147. Alan R. Liss, New York.
  • 9
    Bennett, J.H. (1845) Two cases of disease and enlargement of the spleen in which death took place from the presence of purulent matter in the blood. Edinburgh Medical Surgical Journal, 64, 413 423.
  • 10
    Bierman, P.J. & Armitage, J.O. (1999) Autologous hematopoietic cell transplantation in Hodgkin's disease. In: Hematopoietic Cell Transplantation, 2nd edn (ed. by E.D.Thomas, K.G.Blume & S.J. Forman), pp. 952 962. Blackwell Science, Boston.
  • 11
    Blum, R.H., Carter, S.K., Agre, K. (1973) A clinical review of bleomycin: a new, antineoplastic agent. Cancer, 31, 903 913.
  • 12
    Bonnadonna, G. & Santoro, A. (1982) Evolution in the treatment strategy of Hodgkin's disease. Advances in Cancer Research, 36, 257 293.
  • 13
    Bonnadonna, G., Zucali, R., De Monfardini, S., Lena, M., Uslenghi, G. (1975) Combination therapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine and imidazole carboxamide versus MOPP. Cancer, 36, 252 259.
  • 14
    Bonnadonna, G., Valagussa, P., Santoro, A. (1986) Alternating non cross-resistant combination chemotherapy or MOPP chemotherapy in Stage IV Hodgkin's disease: a report of 8-year results. Annals of Internal Medicine, 104, 739 746.
  • 15
    Brill, N.F., Baehr, G., Rosenthal, N. (1925) Generalized giant lymph node hyperplasia of lymph nodes and spleen. A hitherto undescribed type. Journal of American Medical Association, 84, 668 671.
  • 16
    Burkitt, D.P. (1958) A sarcoma involving the jaws of African children. British Journal of Surgery, 46, 218 223.
  • 17
    Canellos, G.P., Anderson, J.R., Propert, K.J., Nissen, N., Cooper, M.R., Henderson, E.S., Green, M.R., Gottlieb, A., Peterson, B.A. (1992) Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. New England Journal of Medicine, 327, 1478 1484.
  • 18
    Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W., Tubiana, M. (1971) Report of the committee on Hodgkin's disease staging classification. Cancer Research, 31, 1860 1861.
  • 19
    Cohnheim, J. (1865) Ein Fall von Pseudoleukamie. Archives of Anatomical Pathology, 33, 451.
  • 20
    Dalla-Favera, R., Bregni, M., Erickson, J., Patterson, D., Gallo, R.C., Croce, C.M. (1982) Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proceedings of the National Academy of Science of the United States of America, 79, 7824 7827.
  • 21
    DeVita, V.T., Serpick, A., Carbone, P.P. (1970) Combination chemotherapy in the treatment of Hodgkin's disease. Annals of Internal Medicine, 73, 881 895.
  • 22
    DeVita, V.T., Canellos, G.P., Chabner, B., Schein, P., Hubbard, S.P., Young, R.C. (1975) Advanced diffuse histiocytic lymphoma, a potentially curable disease: Results with combination chemotherapy. Lancet I, 248 250.
  • 23
    DeVita, V.T. Jr, Hubbard, S.M., Longo, D.L. (1987) The chemotherapy of lymphomas: looking back, moving forward – the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Research, 47, 5810 5824.
  • 24
    Dreschfeld, J. (1892) Clinical lecture on acute Hodgkin's (or pseudoleucocythemia). British Medical Journal, 1, 893 896.
  • 25
    Epstein, M.A., Achong, B.G., Barr, Y.M. (1964) Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet, I, 702 703.
  • 26
    Fifth International Workshop on Chromosomes in Leukemia-Lymphoma (1987) Correlation of chromosome abnormalities with histologic and immunologic characteristics in non-Hodgkin's lymphoma and adult T cell leukemia-lymphoma. Blood, 70, 1554 1564.
  • 27
    Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogen, T.M., Mize, E.M., Glick, J.H., Coltman, C.A. Jr, Miller, T.P. (1993) Comparison of a standard regimen (CHOP) with three intensive regimens for advanced non-Hodgkin's lymphoma. New England Journal of Medicine, 328, 1002 1006.
  • 28
    Fox, H. (1926) Remarks on microscopical preparations made from some of the original tissue described by Thomas Hodgkin, 1832. Annals of Medical History, 8, 370 374.
  • 29
    Frei, E. III (1982) Clinical cancer research: an embattled species. Cancer, 50, 1979 1992.
  • 30
    Fukuhara, S., Rowley, J.D., Variakojis, D., Golomb, H.M. (1979) Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Research, 39, 3119 3128.
  • 31
    Gaidano, G. & Dalla-Favera, R. (1997) Molecular biology of lymphomas. In: Cancer: Principles & Practice of Oncology, 5th edn (ed. by V.T.Devita, S.HellmanJr & S.A.Rosenberg), pp. 2131 2140. Lipincott-Raven, Boston.
  • 32
    Gall, E.A. & Mallory, T.B. (1942) Malignant lymphoma: a clinico-pathological survey of 618 cases. American Journal of Pathology, 18, 381 429.
  • 33
    Gallo, R.C. & Wong-Staal, F. (1982) Retroviruses as etiologic agents of some animal and human leukemias and lymphomas and as tools for elucidating the mechanisms of leukemogenesis. Blood, 60, 545 557.
  • 34
    Gilbert, R. (1939) Radiotherapy in Hodgkin's disease (malignant lymphogranulomatosis). Anatomic and clinical foundations; governing principles; results. American Journal of Roentgenology, 41, 198 241.
  • 35
    Glatstein, E., Guernsey, J.M., Rosenberg, S.A., Kaplan, H.S. (1969) The value of laparotomy and splenectomy in the staging of Hodgkin's diease. Cancer, 24, 709 718.
  • 36
    Goldie, J.H., Coldman, A.J., Gudauskas, G.A. (1982) Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treatment Reports, 66, 439 449.
  • 37
    Goodman, L.S., Wintrobe, M.M., Dameshek, W., Goodman, M.J., Gilman, A.Z., McLennan, M.I. (1946) Nitrogen mustard therapy. Use of methyl-bis (beta-chloroethyl) amino hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. Journal of the American Medical Associateion, 132, 126 132.
  • 38
    Gottlieb, J.A., Gutterman, J.U., McCredie, K.B., Rodgriguez, V., Frei, E. III (1973) Chemotherapy of malignant lymphoma with Adriamycin. Cancer Research, 33, 3024 3028.
  • 39
    Greenfield, W.S. (1878) Specimens illustrative of the pathology of lymphadenoma and leucocythemia. Transactions of the Patholology Society of London, 29, 272 304.
  • 40
    Gruss, H.J., Pinto, A., Duyster, J., Poppema, S., Hermann, F. (1997) Hodgkin's disease: a tumor of disturbed immunological pathways. Immunolology Today, 18, 156 163.
  • 41
    Gunz, F.W. (1980) The dread leukemias and lymphomas: their nature and their prospects. In: Blood, Pure and Eloquent: A Story of Discovery of People and of Ideas (ed. by M.M.Wintrobe), p. 511. McGraw-Hill, New York.
  • 42
    Hardwick, C. (1966) Thomas Hodgkin. 1798–1866. Guy's Hospital Reports, 115, 255 267.
  • 43
    Harrington, D.S., Weissenberger, D.D., Purtilo, D.T. (1987) Malignant lymphomas in X-linked lymphoproliferative disease. Cancer, 59, 1419 1429.
  • 44
    Harris, N.L., Jaffe, E.S., Banks, P.M., Chan, J.K.C., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Muller-Hermelink, H.-K., Pileri, S.A., Piris, M.A., Ralfkiaer, E., Warnke, R.A. (1994) A revised European-American classification of malignant lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood, 84, 1361 1392.
  • 45
    Hockenberry, D., Nunez, G., Milliman, C., Schreiber, R.D., Korsmeyer, S.J. (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death . Nature, 348, 334 336.
  • 46
    Hodgkin, T. (1832) On some morbid appearances of absorbant glands and spleen. Medico-Chirurgical Transactions, 17, 68 114.
  • 47
    Hoppe, R.T. (1997) Hodgkin's disease: complication of therapy and excess mortality. Annals of Oncology., 8, S115 S118.
  • 48
    Horning, S.J. & Nademanee, A.P. (1999) Autologous hematopoietic cell transplanation for non-Hodgkin's lymphoma. In: Hematopoietic Cell Transplantation, 2nd edn (ed. by E.D.Thomas, K.G.Blume & S.J.Forman), pp. 939 951. Blackwell Science, Boston.
  • 49
    Hoster, H.A., Dratman, M.B., Craver, L.F., Rolnick, H.A. (1948) Hodgkin's disease, 1832–1947. Cancer Research, 8, 49 78.
  • 50
    Hryniuk, W. & Bush, H. (1984) The importance of dose intensity in chemotherapy of metastatic breast cancer. Journal of Clinical Oncology, 2, 1281 1288.
  • 51
    International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. New England Journal of Medicine, 329, 987 994.
  • 52
    Isaacon, P. & Wright, D.H. (1978) Malignant lymphoma of mucosa-associated lymphoid tissue: a distinctive type of B cell lymphoma. Cancer, 52, 1410 1416.
  • 53
    Issell, B.F., Rudolph, A.R., Louie, A. (1984) Etoposide: Current Status and New Developments. Academic Press, New York.
  • 54
    Jackson. H.J. Jr & Parker, F. Jr (1947) Hodgkin's Disease and Allied Disorders. Oxford University Press, New York.
  • 55
    Kaplan, H.S. (1962) The radical radiotherapy of regionally localized Hodgkin's disease. Radiology, 78, 553 561.
  • 56
    Kaplan, H.S. (1980) Hodgkin's Disease, 2nd edn. Harvard University Press, Cambridge MA.
  • 57
    Kass, A.M. & Kass, E.H. (1988) Perfecting the World: The Life and Times of Thomas Hodgkin (1798–1966). Harcourt Brace Jovanovich, Boston.
  • 58
    Kinmonth, J.D. (1952) Lymphangiography in man: Method of outlining lymphatic trunks and operation. Clinical Science, 11, 132 200.
  • 59
    Knowles, D.M. (1992) Neoplastic Hematopathology. Williams & Wilkins, Baltimore.
  • 60
    Korsmeyer, S.J., Hieter, P.A., Ravetch, J.V., Poplack, D.G., Waldmann, T.A., Leder, P. (1981) Developmental hierarchy of immunoglobulin gene rearrangements in human leukemia pre-B cells. Proceedings of the National Academy of Science of the United States of America, 78, 7096 7100.
  • 61
    Kundrat, H. (1893) Uber Lympho-sarkomatosis. Wien Klin Wochenschr, 6, 234 239.
  • 62
    Küppers, R. & Rajewsky, K. (1998) The origin of Hodgkin's and Reed/Sternberg cell in Hodgkin's disease. Annual Review of Immunology, 16, 471 493.
  • 63
    Küppers, R., Klein, U., Hansmann, M.-L., Rajewsky, K. (1999) Cellular origin of human B-cell lymphomas. New England Journal of Medicine, 341, 1520 1529.
  • 64
    Lacher, M.J. & Durant, J. (1965) Combined vinblastine and chlorambucil therapy of Hodgkin's disease. Annals of Internal Medicine, 62, 468 476.
  • 65
    Land, H., Parada, L.F., Weinberg, R.A. (1983) Cellular oncogenes and multistep carcinogenesis. Science, 222, 771 778.
  • 66
    Lennert, K. (1973) Follicular lymphoma. A tumor of the germinal centers. In: Malignant Diseases of the Hematopoietic System (ed. by by K.Akazaki, H.Rappaport, C.W.Berard, J.M.Bennett & E.Ishikawa). GANN Monograph on Cancer Research, Vol. 15, pp. 217 231. University of Tokyo Press, Tokyo.
  • 67
    Lennert, K. & Feller, A.C. (1992) Histopathology of Non-Hodgkin's Lymphoma (Based on the Updated Kiel Classification), 2nd edn. Springer-Verlag, Berlin.
  • 68
    Lennert, K., Mohri, N., Stein, H., Kaiserling, E., Hermelink, H.K. (1978) Malignant Lymphomas other than Hodgkin's Disease. Histology, Cytology, Ultrastructure, Immunology. Springer-Verlag, New York.
  • 69
    Lenoir, G.M. (1986) Role of the virus, chromosomal translocations and cellular oncogenes in the etiology of Burkitt's lymphoma. In: The Epstein-Barr Virus. Recent Advances (ed. by M.A.Epstein and B.G. Achong), p. 183. Wiley, New York.
  • 70
    Lessner, H.E. (1968) BCNU (1, 3 bis (beta-chloroethyl)-1-nitrosurea: effects on advanced Hodgkin's disease and other neoplasms. Cancer, 22, 451 456.
  • 71
    Link, M.P., Shuster, J.J., Donaldson, S.S., Berard, C.W., Murphy, S.B. (1997) Treatment of children and young adults with early stage non-Hodgkin's lymphoma. New England Journal of Medicine, 337, 1259 1266.
  • 72
    Lister, T.A., Crowther, D., Sutcliffe, S.B., Glatstein, E., Canellos, G.P., Young, R.C., Rosenberg, S.A., Coltman, C.A., Tubiana, M. (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswold Meeting. Journal of Clinical Oncology, 7, 1630 1636.
  • 73
    Lukes, R.J. & Butler, J.J. (1966) The pathology and nomenclature of Hodgkin's disease. Cancer Research, 26, 1063 1081.
  • 74
    Lukes, R.J. & Collins, R.D. (1974) Immunologic characterization of human malignant lymphomas. Cancer, 34, 1488 1503.
  • 75
    Lukes, R.J., Craver, L.F., Hall, T.C., Rappaport, H., Rubin, P. (1966) Report of the nomenclature committee. Cancer Research, 26, 1311.
  • 76
    McKelvey, E.M., Gottlieb, J.A., Wilson, H.E., Haut, A., Talley, R.W., Stephens, R., Lane, M., Gamble, J.F., Jones, S.E., Grozca, D.N., Gutterman, J., Coltman, C. Jr, Moon, T.E. (1976) Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer, 38, 1484 1493.
  • 77
    Manolov, G. & Manolova, Y. (1972) Marker band in one chromosome 14 from Burkitt lymphoma. Nature, 237, 33 34.
  • 78
    Mathé, G., Schweisguth, O., Schneider, M., Amiel, J.L., Berumen, L., Brule, G., Cattan, A., Schwartzenberg, L. (1963) Methyl-hydrazine in treatment of Hodgkin's disease. Lancet II,1077 1080.
  • 79
    Minden, M.D., Toyonaga, B., Ha, K., Yanagi, Y., Chin, B., Gelfand, E., Mak, T. (1985) Somatic rearrangement of T-cell antigen receptor genes in human T-cell malignancies. Proceedings of the National Academy of Sciences of the United States of America, 82, 1224 1227.
  • 80
    National Cancer Insitute Division of Cancer Control (1987) Annual Cancer Statistics Review Including Cancer Trends: 1950–85. National Institutes of Health Publication, 88–2729: National Cancer Institute, Bethesda, Maryland.
  • 81
    Niedobitek, G. (1996) The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease. Annals of Oncology, 7, S11 S17.
  • 82
    Niedobitek, G. & Young, L.S. (1997) Epstein-Barr virus and non-Hodgkin's lymphoma. In: The Non-Hodgkin's Lymphomas, 2nd edn (ed. by I.Magrath), pp. 309 329. Arnold/Oxford University Press, London/New York.
  • 83
    Nobel, R.L., Beer, C.T., Cutts, J.H. (1958) Role of chance observation in chemotherapy. Annals of the New York Academy of Science, 76, 882 894.
  • 84
    Offit, K., Lo Coco, F., Louie, D.C., Parsa, N.Z., Leung, D., Portlock, C.Y.E.B.H., Lister, F., Filippa, D.A., Rosenbaum, A., Ladanyi, M., Jhanwar, S., Dalla-Favera, R., Chaganti, R.S.K. (1994) Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma . New England Journal of Medicine, 331, 74 80.
  • 85
    Penn, I. (1993) Tumors after renal and cardiac transplantation. Hematology/Oncology Clinics of North America, 7, 421 445.
  • 86
    Peters, M.V. (1950) A study of survivals in Hodgkin's disease treated radiologically. American Journal of Roentgenology, 63, 299 311.
  • 87
    Peters, M.V. & Middlemiss, K.H.C. (1958) A study of Hodgkin's disease treated by radiation therapy. American Journal of Roentgenology, 79, 114 121.
  • 88
    Preud'homme, J. & Seligmann, M. (1972) Surface bound immunoglobulin as a cell marker in human lymphoproliferative diseases. Blood, 40, 777 794.
  • 89
    Pusey, W.A. (1902) Cases of sarcoma and of Hodgkin's disease treated by exposures to x-rays: a preliminary report. Journal of the American Medical Association, 38, 166 169.
  • 90
    Rappaport, H., Winter, W.J., Hicks, E.B. (1956) Follicular lymphoma. A re-examination of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer, 9, 792 821.
  • 91
    Reed, D.M. (1902) On the pathological changes in Hodgkin's disease, with especial reference to its relation to tuberculosis. Johns Hopkins Hospital Reports, 10, 133 196.
  • 92
    Reis, M.D., Griesser. H., Mak, T.W. (1989) T cell receptor and immunoglobulin gene rearrangements in lymphoproliferative disorders. Advances in Cancer Research, 52, 45 80.
  • 93
    Reis, L.A.G., Miller, B.A., Hankey, B.F., Kosary, C.L., Harras, A., Edwards, B.K., eds. (1997) SEER Cancer Statistics Review: 1973–1994. National Cancer Institute, NIH Publication 97–2789.
  • 94
    Reiter, A., Schrappe, M., Parwaresch, R., Henze, G., Muller-Weihrich, S., Sauter, S., Sykora, K.-W., Ludwig, W.-D., Gadner, H., Riehm, H. (1995) Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage – a report of the Berlin–Frankfort–Munster group. Journal of Clinical Oncology, 13, 359 372.
  • 95
    Rosenberg, S.A. (1966) Report of the committee on the staging of Hodgkin's disease. Cancer Research, 26, 1310.
  • 96
    Rosenberg, S.A., Berard, C.W., Brown, B.W. Jr, Burke, J., Dorfman, R.F., Glatstein, E., Hoppe, R.T., Simon, R. (1982) National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer, 49, 2112 2135.
  • 97
    Rosenberg, C.L., Wong, E., Petty, E.M., Bale, A.E., Tsujimoto, Y., Harris, N.L., Arnold, A. (1991) PRAD1, a candidate bcl-1: mapping and expression in centrocytic lymphoma . Proceedings of the National Acadademy of Science of the United States of America, 88, 9638 9642.
  • 98
    Roulet, F. (1930) Das primare Retothelsarkom der Lymphknoten. Virchows Archives of Pathology and Anatomy, 277, 15 47.
  • 99
    Rowley, J.D. (1982) Identification of the constant chromosome regions involved in human hematologic malignant disease. Science, 216, 749 747.
  • 100
    Sandlund, J.T., Downing, J.R., Crist, W.T. (1996) Non-Hodgkin's lymphoma of childhood. New England Journal of Medicine, 334, 1238 1248.
  • 101
    Schwab, U., Stein, H., Gerdes, J., Lanke, H., Kirschner, H., Schaadt, M., Diehl, V. (1982) Production of a monoclonal antibody specific for Hodgkin and Reed-Sternberg cells in Hodgkin's disease and a subset of normal lymphoid cells. Nature, 299, 65 67.
  • 102
    Sternberg, C. (1898) Uber eine eigenartige unter dem Bilde der Pseudoleukamic verlaufende Tuberculose des lymphatischen Apparates. Ztchr Heilk, 19, 21 90.
  • 103
    Symmers, D. (1927) Follicular lymphadenopathy with splenomegaly. A newly recognized disease of the lymphatic system. Archives of Pathology and Laboratory Medicine, 3, 816 820.
  • 104
    Taub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S., Leder, P. (1982) Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt's lymphoma and murine plasmacytoma cells. Proceedings of the National Academy of Science of the United States of America, 79, 7837 7841.
  • 105
    Thomas, E.D. (1999) Historical review: a history of hematopoietic cell transplantion. British Journal of Haematology, 105, 330 339.
  • 106
    Tsujimoto, Y., Finger, L.R., Yunis, J., Nowell, P.C., Croce, C.M. (1984) Cloning the breakpoint of neoplastic B cells with the t(14; 18) chromosome translocation. Science, 226, 1098 1099.
  • 107
    Twomey, J.J. & Rice, L. (1980) Impact of Hodgkin's disease on the immune system. Seminars in Oncology, 7, 114 125.
  • 108
    Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., Uchino, H. (1977) Adult T-cell leukemia. clinical and hematologic features of 16 cases. Blood, 50, 481 492.
  • 109
    Virchow, R. (1845) Weisses Blut. Neue Notizen aus dem Gebiet der Natur-fund Heilkunde. Floriep's Neue Notizen, 36, 151.
  • 110
    Virchow, R. (18641865) Die Krankenhaften Geschwulste. In: Dreissig Vorlesungen gehalten wahrend des Wintersemestes (1862–1863) an der Universitat zu Berlin, Vol. 2, pp. 728 738. A Hirschwald, Berlin.
  • 111
    Waldmann, T.A., Davis, M.M., Bongiovanni, K.F., Korsmeyer, S.J. (1985) Rearrangements of genes for the antigen receptor on T cells as markers of lineage and clonality in human lymphoid neoplasms. New England Journal of Medicine, 313, 776 783.
  • 112
    Whitelaw, D.M., Cowan, D., Cassidy, F., Patterson, T.A. (1963) Clinical experience with vincristine. Cancer Chemotherapy Reports, 32, 19.
  • 113
    Wilks, Sir, S. (1856) Cases of lardaceous disease and some allied affections, with remarks. Guy's Hospital Reports, 17 (Ser. II, 2), 103 132.
  • 114
    Wilks, Sir, S. (1865) Cases of enlargement of the lymphatic glands and spleen (or, Hodgkin's Disease), with remarks. Guy's Hospital Reports, 11, 56 67.
  • 115
    Wollner, N., Burchenal, J.H., Lieberman, P.H., Exelby, P., D'angio, G., Murphy, M.L. (1976) Non-Hodgkin's lymophoma in children. A comparison of two modalities of therapy. Cancer, 37, 123 134.
  • 116
    Wulczyn, F.G., Naumann, M., Scheidereit, C. (1992) Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kB . Nature, 358, 597 599.
  • 117
    Ye, B.H., Rao, P.H., Chaganti, R.S.K., Dalla-Favera, R. (1993) Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphomas . Cancer Research, 53, 2732 2735.
  • 118
    Yunis, J.J. (1983) The chromosomal basis of human neoplasia. Science, 221, 227 236.
  • 119
    Zech, L., Hoglund, V., Nilsson, K., Klein, G. (1976) Characteristic chromosome abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. International Journal of Cancer, 17, 47 56.
  • 120
    Ziegler, J.L., Beckstead, J.A., Volberding, P.A., Abrams, D.I., Levine, A.M., Lukes, L.J., Gill, P.S., Burkes, R.L., Meyer, P.R., Metroka, C.E., Mouradian, J., Moore, A., Riggs, S.A., Butler, J.J., Cabanillas, F.C., Odajnuk, C., Raohael, B., Koziner, B., Urnacher, C., Clarkson, B.D. (1984) Non-Hodgkin's lymphoma in 90 homosexual men: relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. New England Journal of Medicine, 311, 565 570.